Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), ratio decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), ratio decreased (Expand Search)
-
161
Data for Will et al. 2025 Resting metabolic rate is repeatable, but does not affect call characteristics, in the gray treefrog <i>Hyla chrysoscelis</i>
Published 2025“…We made repeated measurements of RMR across multiple captures of the same individuals to assess the repeatability of metabolic rates, and whether consistency in RMR decreases over time. …”
-
162
Variability in performance and response to task dynamics.
Published 2025“…<p>(A) Upon a change in the required hold time (dashed line), a significant reduction in success rate was similarly observed for both WT and zQ175 mice (RM two-way ANOVA, genotype p = 0.926 F(1, 20) = 0.008736, trial p < 0.0001 F(3.915, 78.31) = 27.99, interaction p = 0.985 F(19, 380) = 0.4237). …”
-
163
Data.
Published 2025“…Ordinal logistic regression was applied to identify factors associated with job satisfaction. Statistical significance was determined by a p-value of less than 0.05 or a 95% confidence interval for the adjusted odds ratio excluding one.…”
-
164
Data Sheet 1_Global impact of Occupational Noise-Induced Hearing Loss (ONIHL): trends, gender disparities, and future projections: 1990–2036.docx
Published 2025“…In 2021, the YLDs rate decreased as the Socio-Demographic Index (SDI) increased across 224 countries, indicating a concentration of the burden in countries with a medium SDI. …”
-
165
Supplementary information–dataset.
Published 2024“…Our previous analysis of these mice found HF diet decreased number of pups born, but increased litter growth rate to postnatal (PN) d12. …”
-
166
Experimental timeline overview.
Published 2024“…Our previous analysis of these mice found HF diet decreased number of pups born, but increased litter growth rate to postnatal (PN) d12. …”
-
167
Cyclization Decoded: Engineering Amylomaltase for Efficient α‑Glucan Transformations
Published 2025“…Furthermore, we identify that postglycosylation noncovalent polysaccharide chain transfer emerges as the decisive factor in cyclization, particularly for AM–degree of polymerization (DP) greater than 30 substrate complexes, where this noncovalent step (≥13.6 kcal/mol) dictates the rate of CA production. 57 variants with enhanced activity (up to a 2.3-fold increase) were engineered in our biochemical experiments by strategically modulating the chain transfer step. …”
-
168
-
169
-
170
Table3_Physiological characteristics and transcriptomic analyses of alfalfa root crown in wintering.docx
Published 2024“…Using RNA sequencing (RNA-Seq) technology, significant genes associated with cold hardiness were found.…”
-
171
Table1_Physiological characteristics and transcriptomic analyses of alfalfa root crown in wintering.docx
Published 2024“…Using RNA sequencing (RNA-Seq) technology, significant genes associated with cold hardiness were found.…”
-
172
Table2_Physiological characteristics and transcriptomic analyses of alfalfa root crown in wintering.docx
Published 2024“…Using RNA sequencing (RNA-Seq) technology, significant genes associated with cold hardiness were found.…”
-
173
Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
-
174
Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
-
175
Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
-
176
Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
-
177
Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
-
178
Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
-
179
Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
-
180
Data Sheet 5_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic...
Published 2025“…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”